Singapore Markets close in 3 mins

Straits Times Index
3,280.29
+14.34(+0.44%)
Nikkei
38,229.11
+155.13(+0.41%)
Hang Seng
18,963.68
+425.87(+2.30%)
FTSE 100
8,432.23
+50.88(+0.61%)
BTC-USD
62,942.25
+1,675.47(+2.73%)
CMC Crypto 200
1,304.28
-53.72(-3.96%)

MacroGenics, Inc. (MGNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

14.67

+0.01

(+0.07%)

At close: 04:00PM EDT

5.45

-9.22

(-62.85%)

Pre-market:

04:56AM EDT

Trade prices are not sourced from all markets

All

GlobeNewswire
MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data
Presentation of interim TAMARACK Phase 2 study data: updated safety and preliminary efficacy of vobra duo in mCRPC patientsConference call scheduled for today at 4:30 p.m. ET ROCKVILLE, Md., May 09, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today provided an update on its recent corporate progress and reported finan
GlobeNewswire
MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
ROCKVILLE, MD, May 03, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the first quarter of 2024 after the market closes on Thursday, May 9, 2024. MacroGenics will host a conference call to discuss the financial results and recent corporate progress on Thursday, M
Simply Wall St.
We're Hopeful That MacroGenics (NASDAQ:MGNX) Will Use Its Cash Wisely
There's no doubt that money can be made by owning shares of unprofitable businesses. Indeed, MacroGenics ( NASDAQ:MGNX...